Actively Recruiting
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
Led by Sun Yat-sen University · Updated on 2020-10-22
10000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are creating a registry and database for patients in China diagnosed with biopsy-confirmed primary IgA nephropathy (IgAN). The study aims to collect detailed patient information and follow these patients annually to assess important health outcomes such as overall mortality, cardiovascular death, and kidney function decline leading to serious kidney failure. Participants include patients with biopsy-proven primary IgAN. The study involves registering patients from multiple hospitals and collecting baseline data including demographics, clinical status, lab tests, complications, and medication use. Follow-up visits occur yearly to update this information and record clinical events like hospitalizations, deaths, and kidney failure requiring dialysis or transplantation. Participants will be followed for up to 10 years, with annual assessments of their health status and kidney function. The research team will analyze the database to compare rates of death and kidney disease progression among IgAN patients. This observational study does not involve experimental treatments and focuses on detailed long-term data collection to better understand disease outcomes.
CONDITIONS
Brief Title
IgA Nephropathy Registration Initiative of High Quality (INSIGHT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy-proven primary IgA nephropathy patients
- Age 14 years or older
- Adequate kidney biopsy sample containing at least 8 glomeruli
You will not qualify if you...
- Secondary causes of mesangial IgA deposition, such as Henoch-Schonlein purpura nephritis, systemic lupus erythematosus, or liver cirrhosis
- Estimated glomerular filtration rate (eGFR) less than 15 ml/min/1.73 m2 at biopsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 10 years
Participants who undergo routine care are observed and their demographic and clinical characteristics, complications, drug information, and clinical events are collected.
Annual visits
Trial Site Locations
Total: 1 location
1
The First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China, 510080
Actively Recruiting
Research Team
X
Xueqing Yu, M.D. & Ph.D
Q
Qiongqiong Yang, M.D. & Ph.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here